The upcoming trials will test the drug at different doses for children as young as 6 years old who test positive for COVID-19 and are not hospitalized, but are also at risk of developing severe disease.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
